Afalaza is a modern over-the-counter medication for the early treatment of benign prostatic hyperplasia (adenoma) and the rehabilitation of men’s health. The medicine not only improves urination and reduces the volume of the prostate gland, but also decreases the risk of adenoma progression, which means there is a chance to protect the gland from painful age-related changes.

Description of the drug

Flat-cylindrical tablets, scored and chamfered, white to off-white colors. On the flat side with a risk, the inscription MATERIA MEDICA is applied, on the other flat the side is marked with the inscription AFALAZA.

Indications for use

Afalase® is indicated for use in adults.

Benign prostatic hyperplasia.
Dysuric disorders (as part of complex therapy): frequent urge to urination, difficulty urinating, pain and discomfort in the area perineum accompanying benign prostatic hyperplasia.

Dosage and administration

inside. 2 tablets, 2 times a day, morning and evening (keep in mouth until full dissolution - outside the meal). The notch is not intended for dividing the tablet into parts.
In dysuric disorders, the drug is recommended to be taken within 16 weeks.
On the recommendation of a doctor for severe pain and dysuric disorders in the first 2-3 weeks of therapy, the drug is indicated up to 4 times a day.
To prevent prostate growth in patients with BPH and reduce the risk of progression of the disease, the drug is recommended to be taken 2 times a day, in the morning and evening for 12 months.